Accelerate Diagnostics Inc reports results for the quarter ended in June - Earnings Summary

Accelerate Diagnostics

08/08/2024 21:44

* Accelerate Diagnostics Inc  AXDX.OQ  reported a quarterly
adjusted loss of 50 cents​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of $-1.31.  The lone analyst forecast for the
quarter was for a loss of 55 cents per share. 
    * Revenue rose 2.2% to $2.99 million from a year ago;
analysts
expected $3.01 million. 
    * Accelerate Diagnostics Inc shares had risen by 15.4% this
quarter and lost 65.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "strong buy"

This summary was machine generated from LSEG data August 8 at
08:43 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       -0.55          -0.50          Beat
 Mar. 31 2024      -0.72          -0.88          Missed
 Dec. 31 2023      -0.62          -0.81          Missed
 Sep. 30 2023      -1.07          0.14           Beat